These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 10743326)

  • 1. Targeted mailing of information to improve uptake of measles, mumps, and rubella vaccine: a randomised controlled trial.
    Mason BW; Donnelly PD
    Commun Dis Public Health; 2000 Mar; 3(1):67-8. PubMed ID: 10743326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 3. ACIP issues recommendations to eliminate measles, rubella and congenital rubella syndrome and to control mumps.
    Rose VL
    Am Fam Physician; 1998 Nov; 58(7):1682, 1685-6. PubMed ID: 9824963
    [No Abstract]   [Full Text] [Related]  

  • 4. Rates of first measles-mumps-rubella immunisation in Wales (UK).
    Thomas DR; Salmon RL; King J
    Lancet; 1998 Jun; 351(9120):1927. PubMed ID: 9654262
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles.
    Bart KJ; Orenstein WA; Hinman AR
    Dev Biol Stand; 1986; 65():45-52. PubMed ID: 3104117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

  • 8. Sentinel surveillance shows small decline in MMR coverage.
    Commun Dis Rep CDR Wkly; 1998 Sep; 8(36):317, 320. PubMed ID: 9782644
    [No Abstract]   [Full Text] [Related]  

  • 9. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
    MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
    Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles lessons learned.
    Scott G
    Nurs Stand; 1996 Jul; 10(44):13. PubMed ID: 8850749
    [No Abstract]   [Full Text] [Related]  

  • 12. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. The Benevento and Compobasso Pediatricians Network for the Control of Vaccine-Preventable Diseases.
    Vaccine; 1998 May; 16(8):818-22. PubMed ID: 9627939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A second dose of MMR vaccine for children in the United Kingdom.
    Commun Dis Rep CDR Wkly; 1996 Jul; 6(30):259. PubMed ID: 8755703
    [No Abstract]   [Full Text] [Related]  

  • 15. MMR vaccine coverage at 24 months stabilises in the UK.
    Commun Dis Rep CDR Wkly; 1999 Mar; 9(13):113, 116. PubMed ID: 10230112
    [No Abstract]   [Full Text] [Related]  

  • 16. Measles, mumps, rubella and the GP.
    Kerrigan P
    Practitioner; 1988 Oct; 232(1456 ( Pt 2)):1121. PubMed ID: 3256857
    [No Abstract]   [Full Text] [Related]  

  • 17. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The measles-mumps-rubella vaccination program in Finland.
    Lerman SJ
    N Engl J Med; 1995 Apr; 332(16):1103. PubMed ID: 7898541
    [No Abstract]   [Full Text] [Related]  

  • 19. Measles, mumps, and rubella vaccine coverage in 2 year old children in East Lancashire--better than it looks.
    Clark A; Marshall R
    Commun Dis Public Health; 1999 Jan; 2(1):50-3. PubMed ID: 10462897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conjugated vaccine against measles, rubella and mumps].
    Vopr Virusol; 1989; 34(1):117-9. PubMed ID: 2728403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.